Getinge AB
Suletud
188.85 0.67
Ülevaade
Aktsiahinna muutus
24h
Min
187.2
Max
189.8
Sissetulek | -511M 2M |
|---|---|
Müük | -440M 7.9B |
P/E Sektori keskmine | 23.06 104.138 |
Aktsiakasum | 2.24 |
Kasumimarginaal | 0.025 |
EBITDA | -554M 861M |
Järgmine tulemuste avaldamine | 28. jaan 2025 |
|---|
Turukapital | 47B |
|---|---|
Eelmine avamishind | 188.18 |
Eelmine sulgemishind | 188.85 |
Getinge AB Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Getinge AB Prognoos
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.